{"id":10553,"date":"2015-12-10T13:19:16","date_gmt":"2015-12-10T13:19:16","guid":{"rendered":"http:\/\/drupal.test\/projects\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/"},"modified":"2022-07-26T15:44:27","modified_gmt":"2022-07-26T19:44:27","slug":"strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/","title":{"rendered":"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire  et le traitement cibl\u00e9 des maladies cardiovasculaires"},"content":{"rendered":"<p>Les maladies cardiovasculaires sont la principale cause de d\u00e9c\u00e8s et d\u2019hospitalisation dans le monde. Au Canada, 80 000 personnes en sont d\u00e9c\u00e9d\u00e9es en 2010, soit 35 % de tous les d\u00e9c\u00e8s au pays. Actuellement, 1,3 million de Canadiens et de Canadiennes sont atteints d\u2019une maladie cardiovasculaire, ce qui repr\u00e9sente un fardeau \u00e9conomique important \u00e9valu\u00e9 \u00e0 22,2 milliards de dollars par ann\u00e9e, le co\u00fbt direct en soins de sant\u00e9 le plus consid\u00e9rable de tous.<\/p>\n<p>L&rsquo;\u00e9quipe, dirig\u00e9e par le D<sup>r<\/sup> Jean- Claude Tardif et M<sup>me<\/sup> Marie-\u00adPierre Dub\u00e9, met \u00e0 profit ses comp\u00e9tences sp\u00e9cialis\u00e9es pour d\u00e9terminer la fa\u00e7on dont les g\u00e8nes influencent l&rsquo;efficacit\u00e9 et la toxicit\u00e9 des m\u00e9dicaments. Elle souhaite ainsi aider les professionnels de la sant\u00e9 \u00e0 choisir un m\u00e9dicament donn\u00e9 et sa posologie dans le but d\u2019am\u00e9liorer les soins aux patients, de r\u00e9duire les effets secondaires n\u00e9fastes et de diminuer les co\u00fbts des soins de sant\u00e9 en r\u00e9duisant l&rsquo;utilisation de m\u00e9dicaments inefficaces et les d\u00e9penses inutiles pour les payeurs de soins de sant\u00e9.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les maladies cardiovasculaires sont la principale cause de d\u00e9c\u00e8s et d\u2019hospitalisation dans le monde. Au Canada, 80 000 personnes en sont d\u00e9c\u00e9d\u00e9es en 2010, soit 35 % de tous les d\u00e9c\u00e8s au pays. Actuellement, 1,3 million de Canadiens et de Canadiennes sont atteints d\u2019une maladie cardiovasculaire, ce qui repr\u00e9sente un fardeau \u00e9conomique important \u00e9valu\u00e9 \u00e0 [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[93],"genome-competitions":[227],"project-sector":[],"genome_centres":[104],"class_list":["post-10553","project","type-project","status-publish","hentry","project-categories-large-scale-science-fr","genome-competitions-concours-2012-projets-de-recherche-appliquee-a-grande-echelle-genomique-et-sante-personnalisee","genome_centres-genome-quebec-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"Les maladies cardiovasculaires sont la principale cause de d\u00e9c\u00e8s et d\u2019hospitalisation dans le monde. Au Canada, 80 000 personnes en sont d\u00e9c\u00e9d\u00e9es en 2010, soit 35 % de tous les d\u00e9c\u00e8s au pays. Actuellement, 1,3 million de Canadiens et de Canadiennes sont atteints d\u2019une maladie cardiovasculaire, ce qui repr\u00e9sente un fardeau \u00e9conomique important \u00e9valu\u00e9 \u00e0 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T19:44:27+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\\\/\",\"name\":\"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2015-12-10T13:19:16+00:00\",\"dateModified\":\"2022-07-26T19:44:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/","og_locale":"fr_FR","og_type":"article","og_title":"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires - GenomeCanada","og_description":"Les maladies cardiovasculaires sont la principale cause de d\u00e9c\u00e8s et d\u2019hospitalisation dans le monde. Au Canada, 80 000 personnes en sont d\u00e9c\u00e9d\u00e9es en 2010, soit 35 % de tous les d\u00e9c\u00e8s au pays. Actuellement, 1,3 million de Canadiens et de Canadiennes sont atteints d\u2019une maladie cardiovasculaire, ce qui repr\u00e9sente un fardeau \u00e9conomique important \u00e9valu\u00e9 \u00e0 [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T19:44:27+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/","url":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/","name":"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2015-12-10T13:19:16+00:00","dateModified":"2022-07-26T19:44:27+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/strategies-de-medecine-personnalisee-visant-le-diagnostic-moleculaire-et-le-traitement-cible-des\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Strat\u00e9gies de m\u00e9decine personnalis\u00e9e visant le diagnostic mol\u00e9culaire et le traitement cibl\u00e9 des maladies cardiovasculaires"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/10553\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=10553"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=10553"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=10553"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=10553"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=10553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}